Health careSocietyWorld

Morocco receives a large shipment AstraZeneca vaccine

Thursday – February 11, 2021 – 17:23

Morocco receives a large shipment of the AstraZeneca vaccine against the Corona pandemic.

An official source has confirmed that a new shipment of the British vaccine “AstraZeneca Oxford”, made in India, will arrive today, Thursday, in Morocco.

The Indian Serum Institute two days ago approved the export of 23.75 million doses of the AstraZeneca corona virus vaccine to 25 countries, including Morocco, Saudi Arabia, Brazil and Nicaragua. , the Morris Islands, the Philippines, Serbia, the United States, the United Arab Emirates and Qatar.

According to identical sources, the expected new shipment to Morocco is expected to contain around 4 million doses, the largest batch received by Morocco since the start of the national vaccination campaign, after the country previously received two million doses of ‘AstraZeneca and half a million doses of Chinese vaccine Sino pharm.

The Ministry of Health has started to widen the circle of beneficiaries of vaccination against the emerging corona virus in the health sector, with Minister Khaled Ait Al-Talib giving instructions to various health centers and hospitals and vaccination centers so that they begin the process of vaccination of doctors within the framework of the age of 40, after being specified in about 40 years Click when launching the campaign.

The number of beneficiaries and women beneficiaries of the vaccination, according to official data, a total of 746,166 people reached the limits last night, Wednesday, according to the daily epidemiological bulletin published by the Ministry of Health.

Morocco is expected to increase vaccination rate after reaching four million doses at a time, which means ensuring vaccination of two million people, which is a major achievement for Morocco given the inability of most countries Africans, even Europeans, with secure access to the quantities requested.

User Rating: 4.49 ( 11 votes)
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
error: Content is protected !!